Match Document Document Title
5955085 Method for the treatment of varicose veins using xanthoxylum from a prickly ash tree  
Bark, berries or tablets of the species Xanthoxylum clava-herculis L and Xanthoxylum americanum Hill, both of the yellow wood tree family, both containing the compound xanthoxylum, are employed...
5952361 Compositions  
The present invention involves the novel use of various classes of drugs, such as H2 and H3 agonists, as erectogenic agents in the treatment of male and female sexual dysfunction.
5952006 Drug preparations for treating impotency  
Topical gelled compositions comprising a drug for treating impotency dispersed within a polymer matrix and treatments using the complex.
5948404 Healthful composition obtained from the hot water extract of Coratceps sinensis mycelia  
This invention is a healthful composition comprising a hot-water extract of the cultivated mycelia of Cordyceps sinensis.The healthful composition of the invention is an oral healthful composition...
5932244 Liposomal human calcitonin gene-related peptide composition and preparation of the same  
The present invention provides a pharmaceutical composition of hCGRP and the preparation of the same. The composition comprises liposomes from nature soybean phospholipid, in which the weight...
5908853 Compositions  
The present invention involves the novel use of H2 and H3 agonists, as erectogenic agents in the treatment of male and female sexual dysfunction in an animal, including humans. The H2 and H3...
5888964 Method for increasing placental blood flow  
A method for increasing the placental blood flow, which comprises administering a human-originated antithrombin-III. The human-originated antithrombin-III increases the placental blood flow in...
5834030 Method of increasing the concentration of nitric oxide in human blood  
A method of increasing the nitric oxide concentration in the blood of a human, which comprises: (a) contacting from about 0.01 ml to about 400 ml of blood with a nitric oxide...
5830497 Medicated plaster containing basic physiologically active agents and/or salts thereof  
Medicated plasters composed of a flexible support and a pressure-sensitive adhesive layer laminated thereon, in which said pressure-sensitive adhesive layer has an exposed surface with pH of 7 or...
5830917 L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors  
There is disclosed a novel amino alcohol amine derivatives of L-N6 -(1-iminoethyl)lysine, pharmaceutical compositions containing these novel compounds, and to their use in therapy, in particular...
5672588 Purine derivatives  
A compound of formula (I), or a pharmaceutically acceptable salt thereof: ##STR1## wherein X is hydrogen, amino, halogen, hydroxy, lower alkoxy or lower alkyl and R1 is ##STR2## wherein Y is...
5668180 Alkoxyaryl compounds  
A compound selected from those of formula (I): ##STR1## in which A, R, Y, R1, R2 and R3 are as defined in the description,and a medicinal product containing the same useful for treating a disorder...
5648101 Drug delivery of nitric oxide  
A method of delivering NO gas to a desired situs on or in the body of a sentient animal, e.g. humans, comprising combining and causing to react a soluble reducing salt, preferably ferrous sulfate,...
5637309 Physiologically active substance-prolonged releasing-type pharmaceutical preparation  
A prolonged releasing pharmaceutical preparation is provided carrying a physiologically active substance, particularly, calcitonin gene-related peptide (CGRP) or a maxadilan (MAX). This...
5616325 Stimulator of vascular endothelial cells and use thereof  
The use of extracts of Tremella fuciformis (Berk) in maintaining the permeability of microvascular walls and its effect on the microcirculatory system, especially with regard to treatment of...
5614542 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use  
Thiazolidine derivatives of formula (I): ##STR1## (in which: R1, R2, R4, R5 are each hydrogen or alkyl; and R3 is hydrogen, aliphatic acyl, alkoxy-carbonyl, or arylcarbonyl and pharmaceutically...
5603918 Aerosol composition of a salt of ipratropium and a salt of albuterol  
The present invention is concerned with an aerosol formulation which contains an effective amount of a pharmaceutically acceptable salt of ipratropium and an effective amount of a pharmaceutically...
5591457 Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human  
A method of inhibiting the aggregation of blood platelets in a human, which comprises: (a) contacting from about 0.01 ml to about 400 ml of blood with a blood platelet aggregation-inhibiting...
5571794 Non-invasive novel method fo cosmetic lip augmentation  
A cosmetic treatment for inducing upper and lower lip augmentation in humans, wherein an active ingredient encouraging vasodilatation, preferably an ultra highly diluted homeopathic, ultra highly...
5565448 Medicament  
The present invention relates to the treatment and prevention of conditions wherein protein Kinase C inhibition is indicated.
5554610 Inhalational treatment of pulmonary hypertension and related conditions  
A method for the treatment and/or prophylaxis of disorders associated with pulmonary hypertension and/or disorders associated with right heart failure, in mammals, such as humans, which method...
5530001 Pharmaceutical use of dihydropyridine derivative  
A novel pharmaceutical use of a dihydropyridine derivative of the formula (I) ##STR1## wherein R1, R2 and R3 are the same or different and each is an alkyl or the like; R4 is a hydrogen atom or...
5527533 Method of retarding and ameliorating central nervous system and eye damage  
A method of retarding and ameliorating eye diseases and injuries is disclosed. The method comprises administering astaxanthin in a therapeutically-effective amount to prevent, retard or treat eye...
5492904 Composition of angiotensin-II receptor antagonists and calcium channel blockers  
Novel pharmaceutical compositions containing a combination of an angiotensin-II antagonist and a calcium channel blocker such as 2-butyl-4...
5461039 Method for treating hypertension employing a cholesterol lowering drug  
A method is provided for treating hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an...
5445812 Angiographic adjuvant  
An angiographic adjuvant comprising a fat emulsion containing a compound having prostaglandin E1 activities, and an angiographic method using the adjuvant.
5441947 Methods of inhibiting vascular restenosis  
Wortmannin and certain of its analogs are inhibitors of restinosis.
5435998 Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents  
Low-tension glaucoma is treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to the optic nerve head. Calcium channel...
5433957 Vasodilating agent  
A vasodilating agent and a hair growth promoting agent comprising an extract of hypericum erectum thunb as an effective component are disclosed. The hypericum erectum thunb extract is prepared...
5431907 Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents  
Ischemic disorders of the retina and associated tissues of the posterior segment of the eye are treated by topical administration to the eye of an amount of a calcium channel blocking agent...
5401503 Hair growth stimulant  
A composition for use in hair growth stimulant and blood circulation stimulant, which contains as active ingredient an extract fraction containing non-aconitine type alkaloidal components which is...
5389675 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents  
Mixed ligand metal complexes of nitric oxide-nucleophile adducts, useful as cardiovascular agents of the formula KA, wherein A is [(M)xx' (L)y (R1 R2 N-N2 O2)x ], andK is a pharmaceutically...
5385914 Cardiotonic carbostyril agents for treating heart ailments  
Method for prophylaxis and treatment of heart diseases using a carbostyril derivative-of formula: ##STR1## wherein R1 is H or CN, and R2 and R3 are each H, alkyl optionally substituted by OH,...
5384123 Topical composition and method for rejuvenating skin  
The invention provides a topical composition for rejuvenating skin texture, comprising a first topically applicable component for stimulating the flow of blood in the arteries leading to, and...
5376672 Method for treating tension type headaches or headaches associated with drugs or their withdrawal  
The present invention provides a new medical use for 3-[2-(dimethylamino)-ethyl]-N-methyl-1H-indole-5-methanesulp honamide and physiologically acceptable salts and solvates thereof in the...
5366997 Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs  
There are disclosed cardiovascularly active compounds possessing antihypertensive properties, and pharmaceutical compositions containing these agents and a method of treating cardiovascular...
5362757 Composition and method containing optically pure (S) metoprolol  
Optically pure (S) metoprolol, which is substantially free of the (R) enantiomer, is a potent beta-blocker for treating myocardial infarction and for relieving the symptoms of angina pectoris,...
5334392 Matrix tablet permitting the sustained release of indapamide after oral administration  
The invention relates to a matrix tablet for the sustained release of indapamide which ensures a continuous and uniform release of the active principle after oral administration.
5294346 Composite microporous membranes  
The composite membrane is disclosed having a microporous support which is coated with a polymer composition and a contact adhesive layer applied to said polymer. A process for making and a process...
5286739 Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor  
An anti-hypotensive formulation comprising an essentially arginine-free or low arginine (less than about 0.1%, most preferably, about 0.01%) containing mixture of amino acids is provided. The...
5281421 Gemfibrozil formulations  
Improved oral formulations are prepared by admixing gemfibrozil with from 1 to 4%, by weight, of a pharmaceutically acceptable surfactant having an HLB value of from about 10 to about 50.
5272153 Method of inhibiting the activity of leukocyte derived cytokines  
A family of compounds effective in inhibiting interleukin-1 (IL-1) activity, tumor necrosis factor (TNF) activity, and the activity of other leukocyte derived cytokines is comprised of...
5268182 Sustained-release drug dosage units of terazosin  
A sustained-release coating composition is described that contains an ethylcellulose and/or a methacrylic methylester together with a plasticizer and a detackifying agent. Sized drug granules are...
5240930 Pharmaceutical compositions for treatment of depression and low blood pressure  
A pharmaceutical composition which comprises a mixture of an alpha-2 adrenoceptor antagonist, preferably idazoxan, or a pharmaceutically acceptable salt thereof, and either a catecholamine...
5225189 Minoxidil gel  
The present invention provides a novel pharmaceutically acceptable gel containing minoxidil for topical application.
5212204 Antihypertensive compositions and use thereof  
This invention concerns antihypertensive compositions and a method of lowering blood pressure in mammals. The active component of the compositions is a compound of the formula: ##STR1## wherein J...
5206264 Use of disulfiram to prevent cardiovascular damage  
A method is disclosed for reducing cardiovascular damage caused by hypoxic or ischemic events such as heart attack and cardiac arrest. This method involves the administration of disulfiram, or a...
5187195 Anthraquinone derivatives and preparation thereof  
Anthraquinone compounds of the formula: ##STR1## wherein: R1 is hydrogen, hydroxy or acyloxy, R2 is hydrogen or acyl, R3 is acyl, R4 is hydrogen or acyl, R5 is hydrogen or acyl, R6 is hydrogen or...
5175179 Method for treating hypertension  
A method of using certain thiazolidine-2,4-diones in the treatment of hypertension.
5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation  
The present invention is directed to a material and method for the stimulation of the production of cytokines. Several polysaccharides, including polymers of different size of ♁1-4 linked...